News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>Citi Expects CHINA LIFE (02628.HK) Interim NP Growth to Slow to 5%, Opens Downside 30-day Catalyst Watch
Citi Research issued a research report opening a downside 30-day catalyst watch on CHINA LIFE (02628.HK), and expressing concerns that the Company's 1H25 earnings growth may fa...
Reset
Send
The window will close in 5 seconds
<Research>Citi Expects CHINA LIFE (02628.HK) Interim NP Growth to Slow to 5%, Opens Downside 30-day Catalyst Watch
Close
Recommend
22
Positive
23
Negative
18
 
 

Citi Research issued a research report opening a downside 30-day catalyst watch on CHINA LIFE (02628.HK)  -0.380 (-1.664%)    Short selling $388.20M; Ratio 31.797%   , and expressing concerns that the Company's 1H25 earnings growth may fall short of expectations, primarily due to declining interest rates, which could dent insurance service fees and net investment income, slower than the market's general expectation of a 20% YoY increase.

The broker currently forecasted that CHINA LIFE's 1H25 net profit will grow by 5% YoY to RMB40.3 billion, a significant slowdown from 1Q25. Therefore, Citi Research kept rating at Buy on CHINA LIFE, with a target price of $26.1, as it remained optimistic about its brand advantage and long-term growth potential.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-08-08 16:25.)

Related NewsHSBC Research: Lower Benchmark PIR for General Insurance Products Benefits CN Insurers; TPs for All Covered Insurers Raised

AASTOCKS Financial News
Website: www.aastocks.com

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.